Article | REF: N4965 V1

Mineral adjuvants for vaccination in oncology

Author: Patrick FRAYSSINET

Publication date: April 10, 2014

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


Français

3. Mineral vaccine adjuvants for use in oncology

3.1 Aluminized compounds

Aluminum compounds including aluminum phosphate (AlPO 4 ), aluminum hydroxide [Al(OH) 3 ] and alum-precipitated vaccines (potassium aluminum sulfate salt: KAl(SO 4 ) 2 · 12H 2 O) remain the most commonly used adjuvants for human and veterinary vaccines. These adjuvants are formed by co-precipitation with the antigen, or brought into the presence of the antigen after adjuvant synthesis. They are relatively difficult to characterize, and their characteristics can vary.

An example of an aluminum salt-based adjuvant...

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Healthcare technologies

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
Mineral vaccine adjuvants for use in oncology